Početna › Rak mjehura › Maryland
Kliničke studije za Rak mjehura u državi Maryland
36 studija za Rak mjehura traži sudionike na lokacijama u državi Maryland.
Gradovi u državi Maryland
Službeni tekst studije (engleski)
Evaluation for NCI Surgery Branch Clinical Research Protocols
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT00001823En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT04235764Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- FMH James M Stockman Cancer Institute, Frederick
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- i još 10
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT00026884Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382DK222 Study at Hopkins
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- i još 2
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07421700A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Johns Hopkins University ( Site 0843), Baltimore
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Johns Hopkins Hospital, Baltimore
- James M Stockman Cancer Institute, Frederick
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07218380Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Anne Arundel Urology, Annapolis
- Chesapeake Urology Research Associates, Hanover
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06567743The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 45 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT06995898Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 120 godina · Oba spola · Ažurirano 28. kol 2026. · NCT02379429FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Johns Hopkins Kimmel Cancer Center, Baltimore
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05614739Measuring Surgical Recovery After Radical Cystectomy
- John Hopkins Medical Institutions, Baltimore
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT03193970A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. kol 2026. · NCT04923178LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- John Hopkins Hospital, Baltimore
- Chesapeake Urology Research Associates, Hanover
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 29. srp 2026. · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- The John Hopkins Hospital, Baltimore
- Maryland Oncology Hematology- Columbia, Rockville
U tijeku regrutacijaFaza 2
Od 8 godina i više · Oba spola · Ažurirano 27. srp 2026. · NCT05503797Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Chesapeake Urology Research Associates, Hanover
U tijeku regrutacija
Od 18 do 88 godina · Oba spola · Ažurirano 2. srp 2026. · NCT06394869Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Frederick Health Hospital, Frederick
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT07327489Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT0531267118F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Oba spola · Ažurirano 19. svi 2026. · NCT06503146Bladder EpiCheck Product Development Study
- Chesapeake Urology Research Associates, Towson
U tijeku regrutacijaOpažajna studija
Od 22 godina i više · Oba spola · Ažurirano 7. tra 2026. · NCT07514143A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 13. velj 2026. · NCT06778863Renal Retention in High Grade Upper Tract Urothelial Cancer
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 8. sij 2026. · NCT05656235Image-Guided Gynecologic Brachytherapy
- The SKCCC at Johns Hopkins, Baltimore
U tijeku regrutacija
Od 18 do 100 godina · Žene · Ažurirano 18. pro 2025. · NCT02993900Blue Light Cystoscopy With Cysview® Registry
- Johns Hopkins Medicine, Baltimore
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 18. pro 2025. · NCT02660645Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 20. stu 2025. · NCT07225205Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
- Johns Hopkins University School of Medicine, Baltimore
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. stu 2025. · NCT06525571Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacija
Od 18 godina i više · Muškarci · Ažurirano 18. stu 2025. · NCT05792722SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- i još 1
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Gender Related Coping and Survivorship for Genitourinary Cancers
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Žene · Ažurirano 3. lis 2025. · NCT05649306Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.